NIFTY VIEW:
Market is expected to open on flat note, we can see Nifty spot to trade around 5280-5275 in opening trade, if Nifty spot able to cross the 5320 level we could see some support buying to initiate in market, Nifty spot is having resistance at 5320-5360 above 5360 we can see some comfort in market and it could move till 5390, whereas Nifty spot is having supports at 5280-5250 below that we may see some selling pressure in market and it could slide lower till 5220.
BOARD MEETING
• AANJANEYA LIFECARE to consider raising funds via QIP.
• BLUE CIRCLE SERVICES to consider foray into infra & realty sectors.
• STEEL EXCHANGE INDIA to allot 5.1 mln equity shares on warrant conversion
DATA ALERT FROM INDIA
• TRADE DATA for January, to be detailed by commerce and industry ministry.
• MANUFACTURING PMI for February, to be detailed by HSBC.
DATA ALERT FROM OVERSEAS
• JAPAN STEEL IMPORTS & EXPORTS STATISTICS for Feb
• JAPAN AUTO SALES DATA for Mar.
• FRANCE MANUFACTURING PURCHASER MANAGERS INDEX for Mar.
• GERMANY MANUFACTURING PURCHASER MANAGERS INDEX.
• EUROZONE MANUFACTURING PURCHASER MANAGERS INDEX for Mar.
• UK CIPS MANUFACTURING PURCHASER MANAGERS INDEX for Mar.
• EU UNEMPLOYMENT DATA for Feb.
• US ISM MANUFACTURING REPORT for Mar.
• US CONSTRUCTION DATA for Feb.
• US GLOBAL MANUFACTURING PURCHASER MANAGERS INDEX for Mar.
MARKET NEWS
• Govt may ask Coal India to ink supply pacts with 80% supply commitment
• Bankers, including SBI, turn down Hotel Leela's plan to recast debt
• Govt allows Titan Industries to import gold directly from overseas
• Reliance MediaWorks allots 2.95 mln pref shrs at 1,000 rupee each
• Eros Int shr up 4%; report parent may list A ordinary shrs in US
• Titan Ind shrs up 5% as govt allows co to import gold directly
• Strides Arcolab shr up 3%; gets US OK for methotrexate injection
• Aurobindo Pharma dn 8%; report MD named in CBI anti-graft case
• Infronics OKs conversion of 1.7 mln warrants at 38 rupees/share
No comments:
Post a Comment